LimousinN, BlascoH, CorciaP, et al.: Malnutrition at the time of diagnosis is associated with a shorter disease duration in ALS. J Neurol Sci, 2010; 297:36–39.
3.
DesportJC, PreuxPM, TruongTC, et al.: Nutritional status is a prognostic factor for survival in ALS patients. Neurology, 1999; 53:1059.
4.
MillerRG, BrooksBR, Swain-EngRJ, et al.: Quality improvement in neurology: Amyotrophic lateral sclerosis quality measures: Report of the quality measurement and reporting subcommittee of the American Academy of Neurology. Neurology, 2013; 81:2136–2140.
5.
AndersenPM, AbrahamsS, BorasioGD, et al.: EFNS guidelines on the clinical management of amyotrophic lateral sclerosis—Revised report of an EFNS task force. Eur J Neurol, 2012; 19:360–375.
6.
MillerRG: The care of the patient with amyotrophic lateral sclerosis: Drug, nutritional, and respiratory therapies (An evidence-based review), Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 2010; 74:781.
7.
CuiF, SunL, XiongJ, et al.: Therapeutic effects of percutaneous endoscopic gastrostomy on survival in patients with amyotrophic lateral sclerosis: A meta-analysis. PLoS One, 2018; 13:e0192243.
BondL, GangulyP, KhamankarN, et al.: A comprehensive examination of percutaneous endoscopic gastrostomy and its association with amyotrophic lateral sclerosis patient outcomes. Brain Sci, 2019; 9:223.
10.
SpataroR, FicanoL, PiccoliF, La BellaV: Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: Effect on survival. J Neurol Sci, 2011; 304:44–48.
11.
Van den BergJP, KalmijnS, LindemanE, et al.: Multidisciplinary ALS care improves quality of life in patients with ALS. Neurology, 2005; 65:1264–1267.
12.
TraynorBJ, AlexanderM, CorrB, et al.: Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: A population based study, 1996–2000. J Neurol Neurosurg Psychiatry, 2003; 74:1258–1261.
13.
LindenbergerE, MeierDE: What special considerations are needed for individuals with amyotrophic lateral sclerosis, multiple sclerosis, or Parkinson disease? In: GoldsteinN, Morrison S (eds): Evidence-Based Practice of Palliative Medicine. Philadelphia, PA: Elsevier Publishing, 2012.
14.
PolsJ, LimburgS: A matter of taste? Quality of life in day-to-day living with ALS and a feeding tube. Cult Med Psychiatry, 2016; 40:361–382.
15.
CzellD, BauerM, BinekJ, et al.: Outcome of percutaneous endoscopic gastrostomy tube insertion in respiratory impaired amyotrophic lateral sclerosis patients under non-invasive ventilation. Respir Care, 2013; 58:838–844.
16.
SeeberAA, PolsAJ, HijdraA, et al.: Advance care planning in progressive neurological diseases: Lessons from ALS. BMC Palliat Care, 2019; 18:50.
17.
EverettEA, PedowitzE, MaiserS, et al.: Top ten tips palliative care clinicians should know about amyotrophic lateral. J Palliat Med, 2020; 23:842–847.
18.
McCluskeyL, HousemanG: Medicare hospice referral criteria for patients with amyotrophic lateral sclerosis: A need for improvement. J Palliat Med, 2004; 7:47–53.
19.
RobinsonMT, EstupinanD: Neuromuscular diseases. In: CreutzfeldtCJ, KlugerBM, Holloway RG (eds). Neuropalliative Care: A Guide to Improving the Lives of Patients and Families Affected by Neurologic Disease. Cham, Switzerland: Springer Nature Switzerland, 2019.
20.
ProGas Study Group: Gastrostomy in patients with amyotrophic lateral sclerosis (ProGas): A prospective cohort study. Lancet Neurol, 2015; 14:702–709.